Abstract
Rurioctocog Alfa Pegol Use in Immune Tolerance Induction: Interim Results from an Open-Label Multicenter Clinical Trial in Previously Untreated Patients with Severe Hemophilia a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have